Soleus Capital Management, L.p.

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
75
Total Value
1388931935
Accession Number
0001802630-25-000006
Form Type
13F-HR
Manager Name
Soleus-Capital-Management-Lp
Data Enrichment
93% identified
70 identified5 unidentified

Holdings

75 positions
Manager:
Search and click to pin securities to the top
Page 1 of 4
78464A870
Shares:1.4M
Value:$113.5M
TG THERAPEUTICS, INC.
Shares:2.8M
Value:$112.2M
NovoCure Ltd
Shares:5.5M
Value:$98.4M
Krystal Biotech, Inc.
Shares:441.8K
Value:$79.6M
BIOMARIN PHARMACEUTICAL INC
Shares:1.1M
Value:$76.3M
Organogenesis Holdings Inc.
Shares:12.5M
Value:$53.9M
Grifols SA
Shares:7.1M
Value:$50.4M
UNITED THERAPEUTICS Corp
Shares:155.4K
Value:$47.9M
STAAR SURGICAL CO
Shares:2.6M
Value:$45.2M
Praxis Precision Medicines, Inc.
Shares:1.1M
Value:$43.2M
08659B102
Shares:3.4M
Value:$41.6M
NeuroPace Inc
Shares:2.6M
Value:$32.1M
Nurix Therapeutics, Inc.
Shares:2.4M
Value:$28.8M
Axogen, Inc.
Shares:1.4M
Value:$26.8M
Celcuity Inc.
Shares:2.6M
Value:$26.0M
IOVANCE BIOTHERAPEUTICS, INC.
Shares:7.8M
Value:$25.9M
SURMODICS INC
Shares:789.1K
Value:$24.1M
INTEGRA LIFESCIENCES HOLDINGS CORP
Shares:1.1M
Value:$23.6M
Terns Pharmaceuticals, Inc.
Shares:8.2M
Value:$22.5M
MADRIGAL PHARMACEUTICALS, INC.
Shares:67.5K
Value:$22.4M